Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study-Reference-Cited by-同舟云学术

Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study

Published:2024-03-01 Issue:4 Volume:63 Page:497-509
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Huygens Sammy^ORCID,Preijers Tim^ORCID,Swaneveld Francis H.,Kleine Budde Ilona,GeurtsvanKessel Corine H.^ORCID,Koch Birgit C. P.^ORCID,Rijnders Bart J. A.^ORCID

Funder

ZonMw

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40262-024-01351-w.pdf

Reference42 articles.

1. Mathieu E. RH, Rodés-Guirao L, Appel C, Giattino C, Hasell J, Macdonald B, Dattani S, Beltekian D, Ortiz-Ospina E, Roser M. Coronavirus (COVID-19) deaths: our world in data; 2022 [updated 30/11/2022. https://ourworldindata.org/covid-deaths.

2. Moreira ED Jr, Kitchin N, Xu X, et al. Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine. N Engl J Med. 2022;386:1910–21. https://doi.org/10.1056/NEJMoa2200674.

3. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–15. https://doi.org/10.1056/NEJMoa2034577.

4. Tenforde MW, Self WH, Adams K, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326:2043–54. https://doi.org/10.1001/jama.2021.19499.

5. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–6. https://doi.org/10.1001/jama.2021.7489.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Applications of Aptamers;International Journal of Molecular Sciences;2024-06-19